GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hangzhou Biotest Biotech Co Ltd (SHSE:688767) » Definitions » EV-to-Revenue

Hangzhou Biotest Biotech Co (SHSE:688767) EV-to-Revenue : 2.05 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Biotest Biotech Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Hangzhou Biotest Biotech Co's enterprise value is ¥972.2 Mil. Hangzhou Biotest Biotech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥474.1 Mil. Therefore, Hangzhou Biotest Biotech Co's EV-to-Revenue for today is 2.05.

The historical rank and industry rank for Hangzhou Biotest Biotech Co's EV-to-Revenue or its related term are showing as below:

SHSE:688767' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.02   Med: 2   Max: 7.56
Current: 2.05

During the past 7 years, the highest EV-to-Revenue of Hangzhou Biotest Biotech Co was 7.56. The lowest was 1.02. And the median was 2.00.

SHSE:688767's EV-to-Revenue is ranked better than
79.03% of 1030 companies
in the Biotechnology industry
Industry Median: 7.73 vs SHSE:688767: 2.05

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), Hangzhou Biotest Biotech Co's stock price is ¥25.40. Hangzhou Biotest Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.49. Therefore, Hangzhou Biotest Biotech Co's PS Ratio for today is 5.66.


Hangzhou Biotest Biotech Co EV-to-Revenue Historical Data

The historical data trend for Hangzhou Biotest Biotech Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Biotest Biotech Co EV-to-Revenue Chart

Hangzhou Biotest Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - 3.16 1.52 3.01

Hangzhou Biotest Biotech Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.61 2.09 2.67 3.01 2.09

Competitive Comparison of Hangzhou Biotest Biotech Co's EV-to-Revenue

For the Biotechnology subindustry, Hangzhou Biotest Biotech Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou Biotest Biotech Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hangzhou Biotest Biotech Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hangzhou Biotest Biotech Co's EV-to-Revenue falls into.



Hangzhou Biotest Biotech Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hangzhou Biotest Biotech Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=972.234/474.052
=2.05

Hangzhou Biotest Biotech Co's current Enterprise Value is ¥972.2 Mil.
Hangzhou Biotest Biotech Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥474.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Biotest Biotech Co  (SHSE:688767) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hangzhou Biotest Biotech Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=25.40/4.489
=5.66

Hangzhou Biotest Biotech Co's share price for today is ¥25.40.
Hangzhou Biotest Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.49.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou Biotest Biotech Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hangzhou Biotest Biotech Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou Biotest Biotech Co (SHSE:688767) Business Description

Traded in Other Exchanges
N/A
Address
No. 17, Futai Road, Zhongtai Street, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311121
Hangzhou Biotest Biotech Co Ltd is engaged in the research and development, manufacturing, sales and service of in vitro diagnostic reagents, raw materials and instruments.

Hangzhou Biotest Biotech Co (SHSE:688767) Headlines

No Headlines